Probi AB Acquires Nutraceutix (TNTGamble, Inc.) for USD 105 million

June 6, 2016

Probi AB, via its U.S. subsidiary Probi USA, Inc., signed an asset purchase agreement to acquire the operations of TNTGamble, Inc. (doing business as Nutraceutix) for a preliminary cash purchase price of USD 105 million. The acquisition substantially expands Probi’s North American presence, adds proprietary delivery technology and manufacturing capacity, brings ~200 customers and ~145 employees, and will be financed with cash, a credit facility and a bridge facility to be refinanced by a proposed SEK 600 million rights issue.

Buyers
Probi AB, Probi USA, Inc. (subsidiary of Probi AB)
Targets
Nutraceutix (TNTGamble, Inc.)
Sellers
TNTGamble, Inc.
Industry
Biotechnology
Location
Washington, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.